home / stock / rvnc / rvnc quote
Last: | $4.235 |
---|---|
Change Percent: | 5.61% |
Open: | $4.07 |
Close: | $4.01 |
High: | $4.31 |
Low: | $3.96 |
Volume: | 1,014,054 |
Last Trade Date Time: | 07/23/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.235 | $4.07 | $4.01 | $4.31 | $3.96 | 1,014,054 | 07-23-2024 |
$4.01 | $3.69 | $4.01 | $4.145 | $3.605 | 1,632,277 | 07-22-2024 |
$3.635 | $3.64 | $3.635 | $3.73 | $3.5601 | 1,085,461 | 07-19-2024 |
$3.65 | $4 | $3.65 | $4 | $3.56 | 2,133,760 | 07-18-2024 |
$3.96 | $4.08 | $3.96 | $4.378 | $3.89 | 3,010,910 | 07-17-2024 |
$4.25 | $3.86 | $4.25 | $4.31 | $3.78 | 2,532,115 | 07-16-2024 |
$3.81 | $3.67 | $3.81 | $3.88 | $3.4402 | 2,246,395 | 07-15-2024 |
$3.58 | $3.36 | $3.58 | $3.7 | $3.33 | 2,797,207 | 07-12-2024 |
$3.27 | $3.03 | $3.27 | $3.32 | $2.97 | 2,339,992 | 07-11-2024 |
$2.91 | $2.91 | $2.91 | $3.09 | $2.85 | 1,344,563 | 07-10-2024 |
$2.89 | $2.78 | $2.89 | $2.98 | $2.75 | 1,299,537 | 07-09-2024 |
$2.795 | $2.73 | $2.795 | $2.88 | $2.71 | 1,439,798 | 07-08-2024 |
$2.67 | $2.63 | $2.67 | $2.74 | $2.59 | 1,097,995 | 07-05-2024 |
$2.68 | $2.43 | $2.68 | $2.68 | $2.41 | 1,091,224 | 07-04-2024 |
$2.68 | $2.43 | $2.68 | $2.68 | $2.41 | 1,091,224 | 07-03-2024 |
$2.42 | $2.59 | $2.42 | $2.59 | $2.395 | 1,182,930 | 07-02-2024 |
$2.57 | $2.57 | $2.57 | $2.75 | $2.53 | 1,762,280 | 07-01-2024 |
$2.57 | $2.58 | $2.57 | $2.64 | $2.47 | 6,732,956 | 06-28-2024 |
$2.58 | $2.36 | $2.58 | $2.58 | $2.31 | 1,835,431 | 06-27-2024 |
$2.34 | $2.35 | $2.34 | $2.41 | $2.3 | 1,264,479 | 06-26-2024 |
News, Short Squeeze, Breakout and More Instantly...
Revance Therapeutics Inc. Company Name:
RVNC Stock Symbol:
NASDAQ Market:
Revance Therapeutics Inc. Website:
- Total net product revenue (DAXXIFY® and RHA® Collection) of $51.7 million, a YoY increase of 13%. - DAXXIFY® net revenue of $22.1 million, after a reduction of $2.0 million related to a consumer coupon program. - Toxin market share increased from 3.0% in Q4’23 to 3...
Conference Call Scheduled for Thursday, May 9, 2024 at 4:30 p.m. ET. Revance Therapeutics, Inc. (NASDAQ: RVNC), today announced that the company will release first quarter 2024 financial results on Thursday, May 9, 2024, after the close of market. Revance will host a corresponding confe...